Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Ipamorelin (INN) (developmental code name NNC 26-0161) is a peptide selective agonist of the ghrelin/growth hormone secretagogue receptor (GHS) and a growth hormone secretagogue.[2][3] It is a pentapeptide with the amino acid sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2 that was derived from GHRP-1.[4] Ipamorelin significantly increases plasma growth hormone (GH).[1][3][5] In addition, ipamorelin stimulates body weight gain in animals.[5] Like pralmorelin and GHRP-6, ipamorelin does not affect prolactin, follicle-stimulating hormone (FSH), luteinizing hormone (LH), or thyroid-stimulating hormone (TSH) levels.[3] However, unlike pralmorelin (GHRP-2) and GHRP-6, but similarly to growth hormone-releasing hormone (GHRH), ipamorelin does not stimulate the secretion of adrenocorticotropic hormone (ACTH) or cortisol, and is highly selective for inducing the secretion only of GH.[3] Ipamorelin Peptide is under active investigation in a number of cell culture and animal models
Quality, Purity & Laboratory Standards Frontier Peptide Labs manufactures research peptides under strict quality control standards designed to support peptide identity, purity, consistency, and reproducibility
A common cycle involves using Ipamorelin for several weeks and then taking a break to allow to recover the body's natural GH producting
Lean mass holds or improves
Managing side effects: practical protocols Having covered individual side effects, let us consolidate the management strategies into practical protocols you can implement
US$ 29.32
US$ 28.42
US$ 23.72
US$ 27.91
US$ 23.58
